DOACs reduce device-related thrombosis and bleeding risk compared to DAPT after left atrial appendage closure
DOACs Show Lower Risk of Blood Clots After Heart Procedure
This meta-analysis of 704 patients with atrial fibrillation undergoing percutaneous left atrial appendage closure found that DOACs significa…
Patients with atrial fibrillation may have a lower risk of blood clots and bleeding when using DOACs after a specific heart procedure.
DOACs reduce stroke, mortality, and major bleeding risk compared to vitamin K antagonists in hemodialysis
DOACs Show Lower Stroke and Bleeding Risk in Dialysis Patients
This meta-analysis evaluated the efficacy and safety of direct oral anticoagulants (DOACs) compared to vitamin K antagonists in patients wit…
Patients with atrial fibrillation on hemodialysis may have lower risks of stroke and major bleeding when using DOACs instead of vitamin K an…
DOACs associated with lower risks of recurrent ICH, ischemic stroke, and mortality in atrial fibrillation
Trial Shows Direct Oral Anticoagulants Reduce Risks for Atrial Fibrillation
This meta-analysis evaluates the efficacy of direct oral anticoagulants (DOACs) compared to vitamin K antagonists (VKAs) in patients with at…
New data suggests that direct oral anticoagulants may lower the risk of stroke and bleeding for patients with atrial fibrillation.
DOAC plus calcium-channel blocker co-use raises major bleeding risk 21% in atrial fibrillation
Combining certain heart medications may increase risk of major bleeding
This meta-analysis of 408,276 patients with atrial fibrillation and elevated thromboembolic risk found that co-use of direct oral anticoagul…
Patients with atrial fibrillation taking both a specific blood thinner and a calcium channel blocker may face a higher risk of serious bleed…
Thromboembolic events cost 2.5-fold more per event than bleeding after high-risk endoscopy
High Risk Endoscopy Procedures Linked to Bleeding in Patients
This retrospective cohort study of 2,486 adults on DOAC or warfarin undergoing high-risk endoscopy found a 22.9% bleeding rate at 90 days an…
Patients with atrial fibrillation undergoing high-risk endoscopy face significant risks of bleeding and stroke, which can lead to high medic…
Direct oral anticoagulants reduce thrombotic events and major bleeding in cirrhosis with atrial fibrillation or venous thromboembolism
Direct oral anticoagulants show promise for patients with liver cirrhosis
A meta-analysis of predominantly observational studies compared direct oral anticoagulants with traditional anticoagulants in patients with …
New analysis suggests direct oral anticoagulants may reduce blood clots and major bleeding risks for patients with liver cirrhosis and heart…
DOAC therapy reduces odds of symptomatic ischemic stroke compared to aspirin monotherapy
Direct oral anticoagulants show lower risk of stroke than aspirin
This meta-analysis of 3666 patients evaluated DOAC therapy versus aspirin for ischemic cerebrovascular disease. The analysis found a lower o…
New data shows that direct oral anticoagulants may offer better protection against symptomatic strokes compared to taking aspirin alone.
Factor XI inhibitors reduce major bleeding but increase ischemic stroke risk in atrial fibrillation
Factor XI inhibitors show lower bleeding risk in atrial fibrillation patients
This meta-analysis of 16852 adults with atrial fibrillation found that Factor XI/XIa inhibitors significantly reduced ISTH major bleeding (O…
A new class of blood thinners may reduce major bleeding risks for people with atrial fibrillation, but they also show higher stroke rates.
LMWH remains useful when oral anticoagulants are difficult to use safely in venous thromboembolism patients
Low-molecular-weight heparin remains useful when oral anticoagulants are difficult to use safely
This narrative review examines low-molecular-weight heparin dosing, anti-factor Xa monitoring, treatment interruption, and switching strateg…
A review suggests low-molecular-weight heparin stays useful when oral anticoagulants are difficult to use safely for patients with venous th…
DOACs versus VKAs for left ventricular thrombus management in adults
Newer Blood Thinners May Be Safer for Heart Clot Patients
A meta-analysis suggests DOACs may be a reasonable alternative to VKAs for left ventricular thrombus, with similar efficacy and potentially …
If you have a blood clot in your heart, newer blood thinners may be just as effective as warfarin with a lower risk of dangerous bleeding.
LAAC and DOACs match warfarin for stroke prevention in AF patients
LAAC and DOACs Cut Bleeding Risk Better Than Warfarin
A network meta-analysis of 78,594 AF patients found LAAC and DOACs offered similar protection against ischemic stroke as warfarin, while sig…
New research shows two new options for atrial fibrillation patients lower bleeding risks while keeping stroke protection the same as older d…
Nurse-led care coordination fails to improve medication adherence in high-need patients
Nurse-led care coordination did not improve medication adherence for most common chronic conditions
This pragmatic randomized controlled trial tested nurse-led care coordination versus usual care in high-need, high-cost commercially insured…
A large trial found that nurse-led care coordination did not improve how often people took their diabetes, heart, or thyroid medications com…
All direct oral anticoagulants Articles
- DOACs reduce stroke, mortality, and major bleeding risk compared to vitamin K antagonists in hemodialysis
- DOACs reduce device-related thrombosis and bleeding risk compared to DAPT after left atrial appendage closure
- DOACs associated with lower risks of recurrent ICH, ischemic stroke, and mortality in atrial fibrillation
- DOAC plus calcium-channel blocker co-use raises major bleeding risk 21% in atrial fibrillation
- Thromboembolic events cost 2.5-fold more per event than bleeding after high-risk endoscopy
- DOAC therapy reduces odds of symptomatic ischemic stroke compared to aspirin monotherapy
- Direct oral anticoagulants reduce thrombotic events and major bleeding in cirrhosis with atrial fibrillation or venous thromboembolism
- Factor XI inhibitors reduce major bleeding but increase ischemic stroke risk in atrial fibrillation
- LMWH remains useful when oral anticoagulants are difficult to use safely in venous thromboembolism patients
- DOACs versus VKAs for left ventricular thrombus management in adults
- LAAC and DOACs match warfarin for stroke prevention in AF patients
- Nurse-led care coordination fails to improve medication adherence in high-need patients
- PRISMA Scoping Review Examines Food-Drug Interactions in Cardiovascular and Diabetic Medications
- Genetic polymorphisms influence pharmacokinetics and bleeding risk for DOACs in meta-analysis
- Meta-analysis of DOACs versus conventional anticoagulation in Kawasaki disease with giant coronary artery aneurysms
- Factor XIa inhibitors show higher stroke risk but lower bleeding risk versus DOACs in atrial fibrillation